Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma

Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma

Abstract Background Dihydropyrimidinase-like 3 (DPYSL3) is a cytosolic phosphoprotein expressed in the nervous system and is crucial for neurogenesis. A previous study showed that increased DPYSL3 expression promotes tumour aggressiveness in pancreatic ductal adenocarcinoma, gastric cancer, and colo...

Full description

Bibliographic Details
Main Authors: Peir-In Liang, Hong-Yue Lai, Ti-Chun Chan, Wei-Ming Li, Chung-Hsi Hsing, Steven K. Huang, Kun-Lin Hsieh, Wen-Hsin Tseng, Tzu-Ju Chen, Wan-Shan Li, Huan-Da Chen, Yu-Hsuan Kuo, Chien-Feng Li
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Cancer
Subjects:
Dihydropyrimidinase-like 3 (DPYSL3)
Upper urinary tracts urothelial carcinoma (UTUC)
Urinary bladder urothelial carcinoma (UBUC)
Cytoskeleton modification
Mammalian target of rapamycin (mTOR)
Ribosomal protein S6 (RPS6)
Online Access:https://doi.org/10.1186/s12885-023-11090-z

Internet

https://doi.org/10.1186/s12885-023-11090-z

Similar Items